150 related articles for article (PubMed ID: 33302303)
1. Hydrogen-Deuterium Exchange Mass Spectrometry Identifies Activated Factor IX-Induced molecular Changes in Activated Factor VIII.
van Galen J; Freato N; Przeradzka MA; Ebberink EHTM; Boon-Spijker M; van der Zwaan C; van den Biggelaar M; Meijer AB
Thromb Haemost; 2021 May; 121(5):594-602. PubMed ID: 33302303
[TBL] [Abstract][Full Text] [Related]
2. Factor VIII-driven changes in activated factor IX explored by hydrogen-deuterium exchange mass spectrometry.
Freato N; Ebberink EHTM; van Galen J; Fribourg C; Boon-Spijker M; van Alphen FPJ; Meijer AB; van den Biggelaar M; Mertens K
Blood; 2020 Dec; 136(23):2703-2714. PubMed ID: 32678887
[TBL] [Abstract][Full Text] [Related]
3. A3 domain region 1803-1818 contributes to the stability of activated factor VIII and includes a binding site for activated factor IX.
Bloem E; Meems H; van den Biggelaar M; Mertens K; Meijer AB
J Biol Chem; 2013 Sep; 288(36):26105-26111. PubMed ID: 23884417
[TBL] [Abstract][Full Text] [Related]
4. Factor VIIIa A2 subunit shows a high affinity interaction with factor IXa: contribution of A2 subunit residues 707-714 to the interaction with factor IXa.
Griffiths AE; Rydkin I; Fay PJ
J Biol Chem; 2013 May; 288(21):15057-64. PubMed ID: 23580639
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants.
Gale AJ; Radtke KP; Cunningham MA; Chamberlain D; Pellequer JL; Griffin JH
J Thromb Haemost; 2006 Jun; 4(6):1315-22. PubMed ID: 16706977
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional characterization of platelet receptor-mediated factor VIII binding.
Ahmad SS; Scandura JM; Walsh PN
J Biol Chem; 2000 Apr; 275(17):13071-81. PubMed ID: 10777612
[TBL] [Abstract][Full Text] [Related]
7. Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase.
Jenkins PV; Dill JL; Zhou Q; Fay PJ
Biochemistry; 2004 May; 43(17):5094-101. PubMed ID: 15109268
[TBL] [Abstract][Full Text] [Related]
8. Maturation of coagulation factor IX during Xase formation as deduced using factor VIII-derived peptides.
Fang H; Zögg T; Brandstetter H
FEBS Open Bio; 2019 Aug; 9(8):1370-1378. PubMed ID: 31077577
[TBL] [Abstract][Full Text] [Related]
9. Binding of factor VIIIa and factor VIII to factor IXa on phospholipid vesicles.
Duffy EJ; Parker ET; Mutucumarana VP; Johnson AE; Lollar P
J Biol Chem; 1992 Aug; 267(24):17006-11. PubMed ID: 1512239
[TBL] [Abstract][Full Text] [Related]
10. Replacing the factor VIII C1 domain with a second C2 domain reduces factor VIII stability and affinity for factor IXa.
Wakabayashi H; Fay PJ
J Biol Chem; 2013 Oct; 288(43):31289-97. PubMed ID: 24030831
[TBL] [Abstract][Full Text] [Related]
11. Structural investigation of zymogenic and activated forms of human blood coagulation factor VIII: a computational molecular dynamics study.
Venkateswarlu D
BMC Struct Biol; 2010 Feb; 10():7. PubMed ID: 20184747
[TBL] [Abstract][Full Text] [Related]
12. Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complex.
Jenkins PV; Freas J; Schmidt KM; Zhou Q; Fay PJ
Blood; 2002 Jul; 100(2):501-8. PubMed ID: 12091341
[TBL] [Abstract][Full Text] [Related]
13. Structural insights into the interaction of blood coagulation co-factor VIIIa with factor IXa: a computational protein-protein docking and molecular dynamics refinement study.
Venkateswarlu D
Biochem Biophys Res Commun; 2014 Sep; 452(3):408-14. PubMed ID: 25157807
[TBL] [Abstract][Full Text] [Related]
14. Model for the factor VIIIa-dependent decay of the intrinsic factor Xase. Role of subunit dissociation and factor IXa-catalyzed proteolysis.
Fay PJ; Beattie TL; Regan LM; O'Brien LM; Kaufman RJ
J Biol Chem; 1996 Mar; 271(11):6027-32. PubMed ID: 8626386
[TBL] [Abstract][Full Text] [Related]
15. Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding.
Schmidt AE; Stewart JE; Mathur A; Krishnaswamy S; Bajaj SP
J Mol Biol; 2005 Jul; 350(1):78-91. PubMed ID: 15913649
[TBL] [Abstract][Full Text] [Related]
16. Stabilizing interactions between D666-S1787 and T657-Y1792 at the A2-A3 interface support factor VIIIa stability in the blood clotting pathway.
Monaghan M; Wakabayashi H; Griffiths AE; Fay PJ
J Thromb Haemost; 2016 May; 14(5):1021-30. PubMed ID: 26878264
[TBL] [Abstract][Full Text] [Related]
17. Probing activation-driven changes in coagulation factor IX by mass spectrometry.
Freato N; van Alphen FPJ; Boon-Spijker M; van den Biggelaar M; Meijer AB; Mertens K; Ebberink EHTM
J Thromb Haemost; 2021 Jun; 19(6):1447-1459. PubMed ID: 33687765
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometry-assisted study reveals that lysine residues 1967 and 1968 have opposite contribution to stability of activated factor VIII.
Bloem E; Meems H; van den Biggelaar M; van der Zwaan C; Mertens K; Meijer AB
J Biol Chem; 2012 Feb; 287(8):5775-83. PubMed ID: 22215677
[TBL] [Abstract][Full Text] [Related]
19. Hemophilia A mutations within the factor VIII A2-A3 subunit interface destabilize factor VIIIa and cause one-stage/two-stage activity discrepancy.
Hakeos WH; Miao H; Sirachainan N; Kemball-Cook G; Saenko EL; Kaufman RJ; Pipe SW
Thromb Haemost; 2002 Nov; 88(5):781-7. PubMed ID: 12428094
[TBL] [Abstract][Full Text] [Related]
20. Factor VIII mutated with Lys1813Ala within the factor IXa-binding region enhances intrinsic coagulation potential.
Nakajima Y; Takeyama M; Oda A; Shimonishi N; Nogami K
Blood Adv; 2023 Apr; 7(8):1436-1445. PubMed ID: 36322904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
